Rubenstein LZ. Falls in older people: Epidemiology, risk factors and strategies for prevention. Age Ageing 2006; 35(Suppl. 2): 37-41.
Tinetti ME, Williams CS. The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol Ser A Biol Sci Med Sci 1998; 53A(2): M112-9.
Hoffman GJ, Hays RD, Wallace SP, et al. Depressive symptomatology and fall risk among community-dwelling older adults. Soc Sci Med 2017; 178: 206-13.
Prizer LP, Smith ML, Housman J, et al. Depressive symptomology management and falls among middle aged and older adults. Aging Ment Health 2016; 20(1): 13-21.
Rao SS. Prevention of falls in older patients. Am Fam Physician 2005; 72(1): 81-8.
Stevens JA. A CDC compendium of effective fall interventions: What works for community-dwelling older adults. Second edition. Inj Prev 2010; pp. 1-159.
Sjösten N, Vaapio S, Kivelä SL. The effects of fall prevention trials on depressive symptoms and fear of falling among the aged: A systematic review. Aging Ment Health 2008; 12(1): 30-46.
Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2011; 10(3): 319-29.
Nicklett EJ, Taylor RJ, Rostant O, et al. Biopsychosocial predictors of fall events among older african americans. Res Aging 2017; 39(4): 501-25.
Nicklett EJ, Taylor RJ. Racial/ethnic predictors of falls among older adults: The health and retirement study. J Aging Health 2014; 26(6): 1060-75.
Hanlon JT, Landerman LR, Fillenbaum GG, et al. Falls in African American and white community-dwelling elderly residents. J Gerontol Ser A Biol Sci Med Sci 2002; 57(7): 473-8.
Stewart WJ, Kowal P, Hestekin H, et al. Prevalence, risk factors and disability associated with fall-related injury in older adults in low- and middle-incomecountries: results from the WHO Study on global AGEing and adult health (SAGE). BMC Med 2015; 13(1): 147.
Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: A prospective study. Diabetes Care 2002; 25(10): 1749-54.
Shumway-Cook A, Ciol MA, Hoffman J, et al. Falls in the Medicare population: Incidence, associated factors, and impact on health care. Phys Ther 2009; 89(4): 324-32.
Villarreal AE, Grajales S, Lopez L, et al. Cognitive impairment, depression, and cooccurrence of both among the elderly in panama: Differential associations with multimorbidity and functional limitations. Biomed Res Int 2016; 2016: 7 pages.
Villarreal AE, O’Bryant SE, Edwards M, et al. Serum-based protein profiles of Alzheimer’s disease and mild cognitive impairment in elderly Hispanics. Neurodegener Dis Manag 2016; 6(3): 203-13.
Villarreal AE, Grajales S, López L, et al. Limitations in activities of daily living among dementia-free older adults in Panama. Ageing Int 2018; 43(2): 1-17.
Folstein MF, Folstein S, McHugh P. Mini Mental Test. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
Blesa R, Pujol M, Aguilar M, et al. Clinical validity of the “Mini-Mental State” for Spanish speaking communities. Neuropsychologia 2001; 39(11): 1150-7.
Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982; 17(1): 37-49.
Izal M, Montorio I. Adaptation of the geriatric depression scale in spain. Clin Gerontol 1993; 13(2): 83-91.
O’Bryant SE, Edwards M, Johnson L, et al. A blood screening test for Alzheimer’ s disease. Alzheimers Dement Diag Assess Dis Monit 2016; 3: 1-8.
O’Bryant SE, Mielke MM, Rissman RA, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2017; 13(1): 45-58.
O’Bryant SE, Xiao G, Zhang F, et al. Validation of a serum screen for alzheimer’s disease across assay platforms, species, and tissues. J Alzheimers Dis 2014; 42(4): 1325-35.
Andresen EM, Wolinsky FD, Miller JP, et al. Cross-sectional and longitudinal risk factors for falls, fear of falling, and falls efficacy in a cohort of middle-aged african americans. Gerontologist 2006; 46(2): 249-57.
de Rekeneire N, Visser M, Peila R, et al. Is a fall just a fall: Correlates of falling in healthy older persons. The health, aging and body composition study. j Am Geriatr Soc 2003; 51(6): 841-6.
Jefferis BJ, Iliffe S, Kendrick D, et al. How are falls and fear of falling associated with objectively measured physical activity in a cohort of community-dwelling older men? BMC Geriatr 2014; 14: 114.
Sekaran NK, Choi H, Hayward RA, et al. Fall-associated difficulty with activities of daily living in functionally independent individuals aged 65 to 69 in the United States: A cohort study. J Am Geriatr Soc 2013; 61(1): 96-100.
Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: A systematic review and meta-analysis. Epidemiology 2010; 21(5): 658-68.
Iaboni A, Flint AJ. The complex interplay of depression and falls in older adults: A clinical review. Am J Geriatr Psychiatry 2013; 21(5): 484-92.
Uusi-Rasi K, Patil R, Karinkanta S, et al. Serum 25-hydroxyvitamin D levels and incident falls in older women. Osteoporos Int 2019; 30(1): 93-101.
Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev 2016; 31: 1-8.
Darvin K, Randolph A, Ovalles S, et al. Plasma protein biomarkers of the geriatric syndrome of frailty. J Gerontol A Biol Sci Med Sci 2014; 69(2): 182-6.
Passtoors WM, van den Akker EB, Deelen J, et al. IL7R gene expression network associates with human healthy ageing. Immun Ageing 2015; 12(1): 21.
Kim HR, Hong MS, Dan JM, et al. Altered IL-7Rα expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 2006; 107(7): 2855.
Banerjee C, Ulloor J, Dillon EL, et al. Identification of serum biomarkers for aging and anabolic response. Immun Ageing 2011; 8: 5.
McKinney EF, Lyons PA, Carr EJ, et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 2010; 16(5): 586-91.
Bikker A, Hack CE, Lafeber FPJG, et al. Interleukin-7: A key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr Pharm Des 2012; 18(16): 2347-56.
Monson NL, Ireland SJ, Ligocki AJ, et al. Elevated CNS inflammation in patients with preclinical Alzheimer’s disease. J Cereb Blood Flow Metab 2014; 34(1): 30-3.
Hu WT, Chen-Plotkin A, Arnold SE, et al. Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment. Acta Neuropathol 2010; 119(6): 669-78.